Related references
Note: Only part of the references are listed.Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
Jian Zhang et al.
ANTI-CANCER DRUGS (2014)
Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial
Volkmar Mueller et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
H-M Lin et al.
BRITISH JOURNAL OF CANCER (2014)
Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Geoffrey R. Oxnard et al.
CLINICAL CANCER RESEARCH (2014)
A new generation of companion diagnostics: cobas BRAF, KRAS and EGFR mutation detection tests
Barbara Angulo et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma
Karen-Lise Garm Spindler et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Clinical relevance of circulating cell-free microRNAs in cancer
Heidi Schwarzenbach et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Predicting distant metastasis and chemoresistance using plasma miRNAs
Jianmei Chen et al.
MEDICAL ONCOLOGY (2014)
DNA methylation markers for early detection of women's cancer: promise and challenges
Timo Wittenberger et al.
EPIGENOMICS (2014)
Circulating Tumor Cells: What Is in It for the Patient? A Vision towards the Future
Anja van de Stolpe et al.
CANCERS (2014)
Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
En-hai Cui et al.
ACTA PHARMACOLOGICA SINICA (2013)
Circulating miR-200c Levels Significantly Predict Response to Chemotherapy and Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer
Koji Tanaka et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Asfar S. Azmi et al.
CANCER AND METASTASIS REVIEWS (2013)
Biologic Challenges in the Detection of Circulating Tumor Cells
Simon A. Joosse et al.
CANCER RESEARCH (2013)
Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor
Kazuko Sakai et al.
CANCER SCIENCE (2013)
Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA
Jacqueline Maier et al.
CLINICAL CANCER RESEARCH (2013)
Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma
Junfang Ji et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients
Mohamad A. Salkeni et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
Peng Wang et al.
MOLECULAR ONCOLOGY (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data
Yoji Kukita et al.
PLOS ONE (2013)
Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
Isolde Summerer et al.
RADIATION ONCOLOGY (2013)
Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
Kevin G. Chen et al.
CLINICAL CANCER RESEARCH (2012)
Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
Rui Liu et al.
CLINICAL CHEMISTRY (2012)
Circulating nucleic acids and protease activities in blood of tumor patients
Heidi Schwarzenbach
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Transformation of non-tumor host cells during tumor progression: theories and evidence
Dolores C. Garcia-Olmo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care
Linnea M. Baudhuin et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non-Small Cell Lung Cancer Patients
Irene Yam et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
MicroRNA profiling: approaches and considerations
Colin C. Pritchard et al.
NATURE REVIEWS GENETICS (2012)
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Hongjiang Wang et al.
PLOS ONE (2012)
Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer
Yu Sun et al.
PLOS ONE (2012)
DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients
Gayatri Sharma et al.
TUMOR BIOLOGY (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA
Tomomi Nakamura et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma
Kazuma Ohyashiki et al.
PLOS ONE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries
Markus Hafner et al.
RNA (2011)
US FDA perspective on challenges in co-developing in vitro companion diagnostics and targeted cancer therapeutics
Reena Philip et al.
BIOANALYSIS (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients
Gayatri Sharma et al.
CLINICAL BIOCHEMISTRY (2010)
Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
Shuhang Wang et al.
CLINICAL CANCER RESEARCH (2010)
Flow Cytometric Analysis of Circulating Microparticles in Plasma
Aaron F. Orozco et al.
CYTOMETRY PART A (2010)
Systemic chemotherapy-induced microsatellite instability in the mononuclear cell fraction of women with breast cancer can be reproduced in vitro and abrogated by amifostine
Jorge L. F. Pinto et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
Yanan Kuang et al.
CLINICAL CANCER RESEARCH (2009)
EGFR Mutations Detected in Plasma Are Associated with Patient Outcomes in Erlotinib Plus Docetaxel-Treated Non-small Cell Lung Cancer
Philip C. Mack et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA
William Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Next-generation DNA sequencing
Jay Shendure et al.
NATURE BIOTECHNOLOGY (2008)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Extracellular nucleic acids
Valentin V. Vlassov et al.
BIOESSAYS (2007)
Role of tumor markers in patients with solid cancers: A critical review
Michael J. Duffy
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
Circulating (cell-free) nucleic acids - A promising, non-invasive tool for early detection of several human diseases
Vishnu Swarup et al.
FEBS LETTERS (2007)
Detection and quantification of mutations in the plasma of patients with colorectal tumors
F Diehl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Circulating tumor-specific DNA: A marker for monitoring efficacy of adjuvant therapy in cancer patients
H Fiegl et al.
CANCER RESEARCH (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
G Gifford et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
